BIOMEA FUSION INC. - COMMON STOCK
6.4400
22-November-24 15:44:58
15 minutes delayed
Stocks
+0.0600
+0.94%
Today's range
6.2300 - 6.7399
ISIN
N/A
Source
NASDAQ
-
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
01 Nov 2024 15:05:51 By Nasdaq GlobeNewswire
-
Biomea Fusion Reports Third Quarter 2024 Financial Results and Corporate Highlights
29 Oct 2024 15:46:08 By Nasdaq GlobeNewswire
-
Biomea Fusion Announces Approval of “icovamenib” as International Nonproprietary Name for BMF-219
21 Oct 2024 08:00:29 By Nasdaq GlobeNewswire
-
15 Oct 2024 15:05:19 By Nasdaq GlobeNewswire
-
07 Oct 2024 08:00:41 By Nasdaq GlobeNewswire
-
01 Oct 2024 08:00:01 By Nasdaq GlobeNewswire
-
FDA Lifts Clinical Hold on BMF-219 in Type 2 and Type 1 Diabetes Trials
26 Sep 2024 13:00:57 By Nasdaq GlobeNewswire
-
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
01 Aug 2024 15:05:20 By Nasdaq GlobeNewswire
-
Biomea Fusion Reports Second Quarter 2024 Financial Results and Corporate Highlights
31 Jul 2024 15:05:22 By Nasdaq GlobeNewswire
-
Biomea Fusion Announces BMF-219 in Diabetes Placed on Clinical Hold
06 Jun 2024 15:05:53 By Nasdaq GlobeNewswire
-
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
03 Jun 2024 15:05:29 By Nasdaq GlobeNewswire
-
30 May 2024 08:12:39 By Nasdaq GlobeNewswire
-
Biomea Fusion Reports First Quarter 2024 Financial Results and Corporate Highlights
02 May 2024 15:05:01 By Nasdaq GlobeNewswire
-
Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
01 May 2024 15:10:28 By Nasdaq GlobeNewswire
-
Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
01 Apr 2024 15:10:59 By Nasdaq GlobeNewswire
-
Biomea Fusion Highlights Initial Data from the First Two Type 1 Diabetes Patients Dosed with BMF-219
01 Apr 2024 08:02:04 By Nasdaq GlobeNewswire
-
Biomea Fusion Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights
01 Apr 2024 08:00:11 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >